In 2013, RS2D succeed to a European Framework Program, FP7 (2013-2017), to build an optimized trimodally (PET/MR/EEG) clinical imaging tool for schizophrenia.

The aim of the project was to design an optimized and a cost-effective trimodally imaging instrument (brain PET/MR/EEG scanner) for early diagnosis, monitoring, and follow-up of schizophrenia disorders. RS2D was the main industrial partner of the project, in charge of the development and construction of the MR part.


The aim of the project was to integrate three well-known imaging modalities in their current clinical applications and to build a new dedicated instrument. In combination with biomarkers from high-end European research laboratories, the new tri-modal PET / MR / EEG scanner is a fully integrated solution for the early diagnosis of schizophrenia.
The consortium develops and build a PET imaging system with better performance than current clinical imaging: spatial resolution of 2 mm and high sensitivity (14%). The PET ring is based on the silicon photomultipliers technology in order to be compatible with the magnetic field and is as compact as possible.
The MRI is based on an ultra-compact superconducting magnet, without the need of cryogenic fluids, and use the latest technology in this field. The electronics developed by RS2D is performing rapid imaging, localized spectroscopy and diffusion weighted imaging.
The PET and the MR is fully integrated in the same compact enclosure and also integrate the electroencephalography system (EEG). This new system is optimized for human brain studies, with improved patient comfort and reduced overall cost compared to existing systems.












Cryogen free superconducting magnet 1.2 m long, weighing only 1.5 tons: (1) Magnet; (2) Gradient coils; (3) RF coil; (4) Technical room, e.g. Gradient Amplifier, Electronics, RF Amplifier


*FP7-Health.2013.221-2-Agreement n°602621